Nursing and Midwifery Board of Australia
Nursing and Midwifery Board of Australia
 

Endorsement for scheduled medicines for midwives

Registration standard

The revised Registration standard: Endorsement for scheduled medicines for midwives came into effect on 1 January 2017.The revised standard combines and replaces the two previous registration standards - Registration standard for endorsement for scheduled medicines for midwives and Eligible midwife registration standard.

Document name PDF Accessible format Date of effect
Registration standard: Endorsement for scheduled medicines for midwives PDF 
(173KB)
Word version 
(395KB,DOCX)
1 January 2017

Additional documents

The following additional documents have been developed to supplement the Registration standard: Endorsement for scheduled medicines for midwives by providing further information to midwives regarding the NMBA’s expectations and requirements.

Document name PDF Accessible format Date of effect
Guidelines: For midwives applying for endorsement for scheduled medicines PDF 
(57.4KB)
Web page 1 January 2017
Fact sheet: Endorsement for scheduled medicines for midwives PDF 
(63.0KB)
Web page 1 January 2017

Consultation process

The revised Registration standard: Endorsement for scheduled medicines for midwives developed after a review of the existing standard, which included public consultation. The consultation report provides an overview of the consultation process, rationale for any changes and sets out the proposed way forward, including areas where further work is planned.

Document name PDF Accessible format Document date
Consultation report: Endorsement for scheduled medicines for midwives PDF 
(274KB)
Word version
(418KB,DOCX)
February 2016

Retired version

Document name PDF Accessible format Date of effect
Retired version: Endorsement for scheduled medicines for midwives registration standard PDF
(307KB)
Word version
(390KB,DOCX)
To 31 December 2016
Retired version: Eligible midwife registration standard PDF 
(187KB)
Word version
(702KB,DOCX)
To 31 December 2016
 
 
 
Page reviewed 7/02/2017